Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 - Concepedia

Concepedia

Publication | Open Access

Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13

DOI Full Paper Access

69

Citations

18

References

2002

Year

Valerio Pittoni, Francesca Romana Spinelli, Rossana Scrivo, Cristiano Alessandri, F. Conti, Antonio Spadaro, Guido Valesini

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1